Download presentation
Presentation is loading. Please wait.
Published byHugh Barber Modified over 8 years ago
1
Department of cardiovascular surgery Kumamoto Central Hospital Taro Nakatsu, Nobushige Tamura, Takuya Nomoto, Koji Hagio, Masanosuke Ishigami, Shouichi Kyo
2
Bilateral internal thoracic artery (BITA) grafting is known to improve the long-term survival after coronary artery bypass grafting (CABG). However, there are few reports regarding the efficacy of BITA grafting in end-stage renal disease (ESRD) patients.
3
1988.10 ~ 2009. 8 154 ESRD patients underwent CABG. 130 patients had CABG with ITAs. SITA 81 patients BITA 49 patients Operation Arrest90 patients VF9 patients On Pump Beating12 patients OPCAB19 patients
4
Follow up duration 5.2±3.8 years 83 patients (63.8%) : Dead Survival Cardiac death Hospital death Cardiogenic death Sudden death Cardiac event Cardiac death Myocardial infarction Reccurent angina Repeated CABGs Repeated PCIs
5
Characteristic SITA (n = 81) BITA (n = 49) P value Age63.8±8.663.7±7.4NS Male 64 (79.0%) 41 (83.7%) NS HT 70 (86.4%) 40 (81.6%) NS HL 23 (28.4%) 20 (40.8%) NS DM 49 (60.5%) 20 (40.8%) 0.0294 Insulin 27 (33.3%) 11 (22.4%) NS CVD 14 (17.3%) 9 (18.4%) NS PVD 22 (27.2%) 10 (20.4%) NS OMI 28 (34.6%) 15 (30.6%) NS Characteristic SITA (n = 81) BITA (n = 49) P value Obesity (BMI>26) 7 (8.6%) 5 (10.2%) NS HD duration5.8±5.09.1±7.2 0.0068 EF64±1465±14NS LMT disease 24 (29.6%) 21 (42.9%) NS 3VD 55 (67.9%) 38 (77.6%) NS 2VD 22 (27.2%) 7 (14.3%) NS 1VD 4 (4.9%) 0NS
6
Variable LITARITA SITA LAD 73 (90%)3 (3.7%) Diag or HL 1 (1.2%)- LCx 4 (4.9%)- BITA LAD 36 (73%)11(22%) Diag or HL 2 (4.1%)6(12%) LCx 11 (22%)32 (65%)
7
SITABITAP value n14145 SVG98.6%93.3%0.0581 n1617 GEA93.8%100%0.2952 n343 RITA100% 1 n6943 LITA98.6%100%0.3974
8
SITA (n = 81) BITA (n = 49) P value Emergent case11(13.5%)1(2.0%)0.0276 Anastomosis3.1±1.13.5±1.00.0433 Use of GEA16 (19.8%) 19 ( 38.8%) 0.0178 Off pump9 (11.1%)10(20.4%)0.1459 Operation time310±67368±71<0.0001 CPB time133±42120±310.083 Cross-clamp time85±2775±280.0934
9
SITA (n = 81) BITA (n = 49) P value In hospital Mortality4 (4.9%)2(4.1%)0.8215 Rethoracotomy1 (1.1%)1 (2.0%)0.7174 Mediastinitis2 (2.5%)2(4.1%)0.605 Perioperative myocardial infarction 4 (4.9%)00.1141 Stroke1 (1.1%)2(4.1%)0.2948 Intestinal complication4 (4.9%)1 (2.0%)0.4051 Multiple organ failure2 (2.5%)2(4.1%)0.605
10
survival Time(years) No. at risk SITA77645334151162 BITA4730242014700 0246810121416 BITA SITA P = 0.1636 0 20% 40% 60% 80% 100% 3 years5 years7 years10 years SITA79.6%62.5%43.6%22.6% BITA76.0%61.9%58.8%33.2%
11
No. at risk SITA77645334151162 BITA4730242014700 0 20% 40% 60% 80% 100% 0246810121416 BITA SITA Time(years) Cumulative Freedom from Cardiac death P = 0.3205 3 years5 years7 years10 years SITA87.1 %80.6%70.7%43.4% BITA85.1%75.3% 60.8%
12
No. at risk SITA77564125863 BITA472719141140 0 20% 40% 60% 80% 100% 02468101214 Time(years) Cumulative Freedom from Cardiac event BITA SITA P = 0.4071 3 years5 years7 years10 years SITA73.9%64.2%51.1%24.6% BITA77.7%60.9%49.6%39.1%
13
DM patients 69 patients (SITA 49 patients, BITA 20 patients) Non DM patients 61 patients (SITA 32 patients, BITA 29 patients)
14
Characteristic SITA (n = 49) BITA (n = 20) P value Age64.4±8.863.6±7.0NS Male 38 (77.6%) 15 (75.0%) NS HT 13 (26.5%) 8 (40.0%) NS HL 23 (28.4%) 20 (40.8%) NS Insulin 27 (55.1%) 11 (55.0%) NS Hb A1c6.9±1.16.4±0.87NS CVD 10 (20.4%) 3 (15.0%) NS PVD 18 (36.7%) 7 (35.0%) NS OMI 18 (36.7%) 4 (20.0%) NS Characteristic SITA (n = 49) BITA (n = 20) P value Obesity (BMI>26) 6 (12.2%) 1 (5.0%) NS HD duration4.5±3.96.1±4.7 NS EF65±1464±15NS LMT disease 15 (30.6%) 10 (50.0%) NS 3VD 36 (73.5%) 14 (70.0%) NS 2VD 9 (27.2%) 6 (30.0%) NS 1VD 2 (4.1%) 0NS
15
0246810121416 No. at risk SITA493831168531 BITA2010864100 P = 0.8449 BITA SITA years survival 0 20% 40% 60% 80% 100% 3 years5 years7 years10 years SITA82.4%63.8%45.9%17.9% BITA82.5%56.6% 9.4%
16
No. at risk SITA493831168531 BITA2010864100 P = 0.6366 BITA SITA 0246810121416 years Cumulative Freedom from Cardiac Death 20% 40% 60% 80% 100% 0 3 years5 years7 years10 years SITA93.3%87.1%72.0%42.3% BITA86.8%77.2% 34.3%
17
No. at risk SITA493528146420 BITA207533000 P = 0.0899 BITA SITA years Cumulative Freedom from Cardiac Event 20% 40% 60% 80% 100% 0 02468101214 3 years5 years7 years10 years SITA85.1%79.1%68.4%35.3% BITA62.9%52.4%39.3%0
18
Characteristic SITA (n = 32) BITA (n = 29) P value Age62.8±8.563.7±7.8NS Male 26 (81.3%) 26 (89.7%) NS HT 27 (84.4%) 24 (82.8%) NS HL 10 (31.3%) 12 (41.4%) NS CVD 4 (12.5%) 6 (20.7%) NS PVD 4 (12.5%) 3 (10.3%) NS OMI 10 (31.3%) 11 (37.9%) NS Characteristic SITA (n = 32) BITA (n = 29) P value Obesity (BMI>26) 1 (3.1%) 4 (13.8%) NS HD duration7.7±5.711.1±8.0 NS EF62±1465±14NS LMT disease 9 (28.1%) 11 (37.9%) NS 3VD 18 (56.3%) 23 (79.3%) 0.0554 2VD 11 (34.3%) 5 (17.2%) NS 1VD 1 (3.1%) 0NS
19
No. at risk SITA292522187631 BITA2720161410600 0 20% 40% 60% 80% 100% 0246810121416 P = 0.0889 BITA SITA years survival 3 years5 years7 years10 years SITA75.0%59.4%40.4%28.3% BITA73.1%64.5%59.9%47.9%
20
0246810121416 P = 0.0895 BITA SITA No. at risk SITA292522187631 BITA2720161410600 years Cumulative Freedom from Cardiac Death 20% 40% 60% 80% 100% 0 3 years5 years7 years10 years SITA77.7%70.9%61.8%43.3% BITA84.2%74.3%
21
02468101214 BITA SITA P = 0.0075 No. at risk SITA292115112210 BITA272014118400 20% 40% 60% 80% 100% 0 Time(years) Cumulative Freedom from Cardiac event 3 years5 years7 years10 years SITA58.4%44.7%35.5%11.8% BITA84.0%64.2%53.4%
22
Bilateral internal thoracic artery grafting produces improved survival compared with single internal thoracic artery grafting during the second postoperative decade.
23
ESRD patients with diabetes mellitus have a increased risk of death 10 years survival BITA:17.9% SITA: 9.4%. Therefore, BITA grafting might confer few advantages for long term survivals.
24
After a long-term follow-up, CABG with BITA grafts showed no advantages in the long-term outcomes among ESRD patients. For ESRD patients without diabetes mellitus, BITA grafting may provide more promising long-term freedom from cardiac events ratio.
Similar presentations
© 2025 SlidePlayer.com. Inc.
All rights reserved.